Expression of carbonic anhydrase IX in craniopharyngiomas: Laboratory investigation

Journal of Neurosurgery

Volumn 115, Issue 4, 2011, Pages 796-801

  Proescholdt, Martin ^a   Merrill, Marsha ^b   Stoerr, Eva Maria ^a   Lohmeier, Annette ^a   Dietmaier, Wolfgang ^a   Brawanski, Alexander ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Angiogenesis; Carbonic anhydrase IX; Cyst formation; Hypoxia; Oncology; P53

Indexed keywords

CARBONATE DEHYDRATASE IX; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN P53; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHILD; CLINICAL ARTICLE; CRANIOPHARYNGIOMA; CYST; FEMALE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MUTATION; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CHILD; CHILD, PRESCHOOL; CRANIOPHARYNGIOMA; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80053387746     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2011.6.JNS1168     Document Type: Article

References (42)

1. Agozzino L, Ferraraccio F, Accardo M, Esposito S, Agozzino M, Cuccurullo L: Morphological and ultrastructural findings of prognostic impact in craniopharyngiomas. Ultrastruct Pathol 30:143-150, 2006 (Pubitemid 44049768)
2. Arefyeva IA, Semenova JB, Zubairaev MS, Kondrasheva EA, Moshkin AV: Analysis of fluid in craniopharyngioma-related cysts in children: proteins, lactate and pH. Acta Neurochir (Wien) 144:551-554, 2002 (Pubitemid 34744046)
3. Ashida S, Nishimori I, Tanimura M, Onishi S, Shuin T: Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma. J Cancer Res Clin Oncol 128:561-568, 2002 (Pubitemid 35244932)
4. Becker B: Carbonic anhydrase and the formation of aqueous humor. Am J Ophthalmol 47:342-361, 1959
5. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM: The descriptive epidemiology of craniopharyngioma. Neurosurg Focus 3(6):e1, 1997
6. Cáceres A: Intracavitary therapeutic options in the management of cystic craniopharyngioma. Childs Nerv Syst 21:705-718, 2005
7. Erdheim J: Über Hypophysenganggeschwülste und Hirncholesteatome. Sitzungsberichte der Kaiserlichen Akademie der Wissenschaften in Wien 113:537-726, 1904
8. Garnett MR, Puget S, Grill J, Sainte-Rose C: Craniopharyngioma. Orphanet J Rare Dis 2:18, 2007
9. Gluszok S, Frédérick R, Foulon C, Klupsch F, Supuran CT, Vullo D, et al: Design, solid-phase synthesis, and biological evaluation of novel 1,5-diarylpyrrole-3-carboxamides as carbonic anhydrase IX inhibitors. Bioorg Med Chem 18:7392-7401, 2010
10. Haapasalo JA, Nordfors KM, Hilvo M, Rantala IJ, Soini Y, Parkkila AK, et al: Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clin Cancer Res 12:473-477, 2006 (Pubitemid 43166138)
11. Haupt R, Magnani C, Pavanello M, Caruso S, Dama E, GarrèML: Epidemiological aspects of craniopharyngioma. J Pediatr Endocrinol Metab 19 (Suppl 1):289-293, 2006
12. Honegger J, Tatagiba M: Craniopharyngioma surgery. Pituitary 11:361-373, 2008
13. Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, et al: Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158:905-919, 2001 (Pubitemid 32221783)
14. Ivanov SV, Kuzmin I, Wei MH, Pack S, Geil L, Johnson BE, et al: Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci U S A 95:12596-12601, 1998 (Pubitemid 28483810)
15. Jane JA Jr, Laws ER: Craniopharyngioma. Pituitary 9:323-326, 2006
16. Järvelä S, Parkkila S, Bragge H, Kähkönen M, Parkkila AK, Soini Y, et al: Carbonic anhydrase IX in oligodendroglial brain tumors. BMC Cancer 8:1, 2008
17. Kaluzová M, Pastoreková S, Pastorek J, Kaluz S: P53 tumour suppressor modulates transcription of the TATA-less gene coding for the tumour-associated carbonic anhydrase MN/CA IX in MaTu cells. Biochim Biophys Acta 1491:20-26, 2000 (Pubitemid 30173329)
18. Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, et al: Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62:397-409, 2005
19. Korkolopoulou P, Perdiki M, Thymara I, Boviatsis E, Agrogiannis G, Kotsiakis X, et al: Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX. Hum Pathol 38:629-638, 2007 (Pubitemid 46399896)
20. Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, Wycoff CC, et al: Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61:6394-6399, 2001 (Pubitemid 32783244)
21. Minniti G, Esposito V, Amichetti M, Enrici RM: The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma. Neurosurg Rev 32:125-132, 2009
22. Momota H, Ichimiya S, Ikeda T, Yamaki T, Kikuchi T, Houkin K, et al: Immunohistochemical analysis of the p53 family members in human craniopharyngiomas. Brain Tumor Pathol 20:73-77, 2003 (Pubitemid 38146274)
23. Montani M, Heinimann K, Von Teichman A, Rudolph T, Perren A, Moch H: VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease. Am J Surg Pathol 34: 806-815, 2010
24. Nozaki M, Tada M, Matsumoto R, Sawamura Y, Abe H, Iggo RD: Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumors of the central nervous system: reappraisal by yeast functional assay. Acta Neuropathol 95: 291-296, 1998 (Pubitemid 28120675)
25. Opavský R, Pastoreková S, Zelník V, Gibadulinová A, Stanbridge EJ, Závada J, et al: Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics 33:480-487, 1996 (Pubitemid 26159864)
26. Pettorini BL, Frassanito P, Caldarelli M, Tamburrini G, Massimi L, Di Rocco C: Molecular pathogenesis of craniopharyngioma: switching from a surgical approach to a biological one. Neurosurg Focus 28(4):E1, 2010
27. Prabhu VC, Brown HG: The pathogenesis of craniopharyngiomas. Childs Nerv Syst 21:622-627, 2005 (Pubitemid 41300439)
28. Proescholdt MA, Mayer C, Kubitza M, Schubert T, Liao SY, Stanbridge EJ, et al: Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro-oncol 7:465-475, 2005 (Pubitemid 41555618)
29. Pugh CW, Ratcliffe PJ: The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin Cancer Biol 13:83-89, 2003 (Pubitemid 36269184)
30. Rankin EB, Tomaszewski JE, Haase VH: Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res 66:2576-2583, 2006
31. Rienstein S, Adams EF, Pilzer D, Goldring AA, Goldman B, Friedman E: Comparative genomic hybridization analysis of craniopharyngiomas. J Neurosurg 98:162-164, 2003 (Pubitemid 36050460)
32. Roberts WG, Palade GE: Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108:2369-2379, 1995
33. Sathornsumetee S, Cao Y, Marcello JE, Herndon JE II, McLendon RE, Desjardins A, et al: Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan. J Clin Oncol 26:271-278, 2008
34. Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, et al: Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 161:1997-2001, 2002 (Pubitemid 35434845)
35. Svastová E, Hulíková A, Rafajová M, Zat'ovicová M, GibadulinováA, Casini A, et al: Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 577:439-445, 2004 (Pubitemid 39535327)
36. Swietach P, Vaughan-Jones RD, Harris AL: Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 26:299-310, 2007 (Pubitemid 47101667)
37. Vaquero J, Zurita M, De Oya S, Coca S, Morales C, Salas C: Expression of vascular permeability factor in craniopharyngioma. J Neurosurg 91:831-834, 1999 (Pubitemid 30053156)
38. Vogh BP: The relation of choroid plexus carbonic anhydrase activity to cerebrospinal fluid formation: study of three inhibitors in cat with extrapolation to man. J Pharmacol Exp Ther 213:321-331, 1980
39. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, et al: Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60:7075-7083, 2000 (Pubitemid 32059187)
40. Yoo H, Baia GS, Smith JS, McDermott MW, Bollen AW, vandenberg SR, et al: Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Clin Cancer Res 13:68-75, 2007 (Pubitemid 46121854)
41. Yoo H, Sohn S, Nam BH, Min HS, Jung E, Shin SH, et al: The expressions of carbonic anhydrase 9 and vascular endothelial growth factor in astrocytic tumors predict a poor prognosis. Int J Mol Med 26:3-9, 2010
42. Yoshimoto M, De Toledo SR, Da Silva NS, Bayani J, Bertozzi AP, Stavale JN, et al: Comparative genomic hybridization analysis of pediatric adamantinomatous craniopharyngiomas and a review of the literature. J Neurosurg 101 (1 Suppl):85-90, 2004